Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 22

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

PK model with concentration-dependent clearance for zuretinol acetate, an oral agent in development for treatment of inherited retinal dystrophy caused by LRAT or RPE65 mutations

Glenn Noronha; Prokash Paul; Barrett Katz; Nathan Teuscher

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4942. doi:

ARVO Annual Meeting Abstract July 2019

Suprachoroidal injection of AAV8 for ocular gene delivery in the nonhuman primate.

Glenn Yiu; Sook Hyun Chung; Iris Natalie Mollhoff; Uyen Tu Nguyen; Sara M Thomasy; Soohyun Kim; Jesse Yoo; Donna Taraborelli; Glenn Noronha

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2904. doi:

ARVO Annual Meeting Abstract July 2019

Suprachoroidally delivered non-viral DNA nanoparticles transfect chorioretinal cells in non-human primates and rabbits

Viral Kansara; Jesse Yoo; Mark J Cooper; Ozge Sensenoglu Laird; Donna Taraborelli; Robert Moen; Glenn Noronha

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2909. doi:

ARVO Annual Meeting Abstract July 2019

Treatment response analysis of visual acuity and central subfield retinal thickness following suprachoroidal CLS-TA

Christopher R Henry; Nathan Teuscher; Craig Comisar; Donna Taraborelli; Barry Kapik; Glenn Noronha

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3511. doi:

ARVO Annual Meeting Abstract July 2018

Choroidal Changes after Suprachoroidal Injection of CLS-TA, Triamcinolone Acetonide Injectable Suspension, in Eyes with Macular Edema Secondary to Retinal Vein Occlusion

Alex Willoughby; Vivian Vuong; David Cunefare; Sina Farsiu; Glenn Noronha; Ronald P Danis; Glenn Yiu

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5969. doi:

ARVO Annual Meeting Abstract June 2017

Characterization of the Dynamics of Liquid and Gel Spread in the Suprachoroidal Space of Enucleated Porcine Eyes

Jesse Yoo; Vladimir Zarnitsyn; Samirkumar Rajnikant Patel; Glenn Noronha

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1110. doi:

ARVO Annual Meeting Abstract June 2017

An analysis of the phase 2 trial with intravitreal aflibercept and suprachoroidal triamcinolone acetonide compared to intravitreal aflibercept alone in retinal vein occlusion patients in terms of perfusion status.

Michael Singer; Glenn Noronha

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2963. doi:

ARVO Annual Meeting Abstract June 2017

Targeted delivery of triamcinolone acetonide and CLS011A to the posterior ocular tissues via suprachoroidal administration

Brian Burke; Samirkumar Rajnikant Patel; Donna Taraborelli; Craig B Struble; Glenn Noronha

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4112. doi:

Clinical Trials December 2016

Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis

PDF

Debra A. Goldstein; Diana Do; Glenn Noronha; Jennifer M. Kissner; Sunil K. Srivastava; Quan D. Nguyen
TAGS: adrenal corticosteroids, glucocorticoids, mineralocorticoids, uveitis, injections
Trans. Vis. Sci. Tech.. 2016; 5(6):14. doi: https://doi.org/10.1167/tvst.5.6.14

ARVO Annual Meeting Abstract September 2016

Efficacy of Suprachoroidal Aflibercept in a Laser Induced Choroidal Neovascularization Model

Samirkumar Rajnikant Patel; Jennifer Kissner; Rafal Farjo; Vladimir Zarnitsyn; Glenn Noronha

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):286. doi:

ARVO Annual Meeting Abstract September 2016

Ocular Tolerability and Toxicokinetics of Suprachoroidally Administered CLS-TA, Triamcinolone Acetonide Injectable Suspension, in Combination with Intravitreal Eylea in Rabbits

Donna Taraborelli; Brian Burke; Glenn Noronha

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):296. doi:

ARVO Annual Meeting Abstract September 2016

Pharmacokinetics Including Ocular Distribution Characteristics of Suprachoroidally Administered CLS011A in Rabbits Could be Beneficial for a Wet AMD Therapeutic Candidate

Jennifer Kissner; Samirkumar Rajnikant Patel; Jeffery J Prusakiewicz; Dennis Alton; Galina Bikzhanova; Lisa Geisler; Brian Burke; Glenn Noronha

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4002. doi:

ARVO Annual Meeting Abstract September 2016

Characterization of Suprachoroidal Injection in Multiple Species

Vladimir Zarnitsyn; Samirkumar Rajnikant Patel; Jesse Yoo; Glenn Noronha

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5032. doi:

ARVO Annual Meeting Abstract June 2015

A phase 1/2 open-label, safety and tolerability study of triamcinolone acetonide administered to the suprachoroidal space in patients with non-infectious uveitis

Debra A Goldstein; Sunil K Srivastava; Quan Nguyen; Glenn Noronha; Michelle Widmann

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3557. doi:

ARVO Annual Meeting Abstract June 2015

Evaluation of suprachoroidal CLS-TA and oral prednisone in a porcine model of uveitis

Glenn Noronha; Kristin Blackwell; Brian C Gilger; Jennifer Kissner; Samirkumar Rajnikant Patel; Kaitlyn T Walsh

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3110. doi:

ARVO Annual Meeting Abstract April 2014

Safety and toxicokinetics of suprachoroidal space (SCS) injections of CLS1001 (triamcinolone acetonide, TA) in albino rabbits

Glenn Noronha; Henry F Edelhauser; Samir Patel; Brian Burke; Rozemarijn S Verhoeven

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4887. doi:

ARVO Annual Meeting Abstract May 2008

Real-Time Fluorometric Quantification of VEGF-Induced Blood-Retinal Barrier Breakdown in Rats

Z. Z. Chen; S. Mahesh; C. Virata; T. Olafson; C. Jaramillo; J. Hood; M. Martin; G. Noronha; R. Soll; J. Doukas

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1380. doi:

ARVO Annual Meeting Abstract May 2008

Topical Dual VEGF Receptor/Src Kinase Inhibition as Potential Therapies for Retinal Edema Associated With Ischemic Retinal Vascular Disorders

S. P. Mahesh; Z. Chen; C. Virata; L. Dellamary; J. Hood; M. Martin; G. Noronha; R. Soll; J. Doukas

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):6114. doi:

ARVO Annual Meeting Abstract May 2007

A Dual VEGFR/JAK2 Kinase Inhibitor Suitable for Topical Delivery Inhibits Choroid Neovascularization in Mice

Z. Z. Chen; C. Mak; J. Renick; D. Lohse; L. Dellamary; M. Martin; J. Hood; G. Noronha; J. Doukas; R. Soll

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1469. doi:

ARVO Annual Meeting Abstract May 2007

A Topically Delivered VEGF/JAK2 Kinase Inhibitor Reduces Oxygen-Induced Retinopathy in a Murine Model

A. L. Racanelli-Layton; B. Tam; T. Olafson; C. Virata; C.-C. Mak; J. Cao; J. Hood; G. Noronha; J. Doukas; R. Soll

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4045. doi:

1 2

Next 20 Results »

Advertisement